<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">C.-C</forename><surname>Yang</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">Good Samaritan Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">Good Samaritan Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">Good Samaritan Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Heller</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Northwestern University Medical School</orgName>
								<address>
									<postCode>1912</postCode>
									<settlement>Chicago, Illinois</settlement>
									<country>USA, USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">USC Neuromuscular Center</orgName>
								<orgName type="institution" key="instit2">Good Samaritan Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">USC Neuromuscular University of Southern California School of Medicine</orgName>
								<address>
									<addrLine>637 South Lucas Avenue</addrLine>
									<postCode>90017</postCode>
									<settlement>Los Center, Los Angeles, -Angeles</settlement>
									<region>CA, CA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Nitric oxide-induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">A37ADF327E6F975A98BBF841B78DF118</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>nitric oxide</term>
					<term>oxidative stress</term>
					<term>hereditary inclusion-body myopathies</term>
					<term>inclusion-body myositis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Autosomal-recessive and autosomal-dominant hereditary inclusion-body myopathies are severe, progressive muscle diseases, characterized pathologically by vacuolated muscle fibres containing paired helical filaments. We immunostained muscle biopsy specimens from quadriceps-sparing autosomal-recessive and autosomaldominant inclusion-body myopathy subjects, diseasecontrol subjects and normal patients, utilizing isoformspecific antibodies against the neuronal and inducible forms of nitric oxide synthase, and antibodies against nitrotyrosine. Approximately 75% of the vacuolated muscle fibres in all recessive and dominant inclusionbody myopathy patients contained inclusions strongly immunoreactive with antibodies against neuronal</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Nitric oxide (NO) is a short-lived reactive gas, synthesized from L-arginine via the catalytic action of nitric oxide synthase (NOS). NOS has three major isoforms: neuronal, inducible and endothelial, each encoded by a different gene <ref type="bibr">(Dawson and Snyder, 1994;</ref><ref type="bibr" target="#b35">Fo ¨rstermann et al., 1994;</ref><ref type="bibr">Nathan and Xie, 1994)</ref>. Neuronal NOS (nNOS) is constitutive, and is stimulated mainly by intracellular Ca 2ϩ via calmodulin. Under certain circumstances, increased transcription of nNOS has been demonstrated <ref type="bibr">(Dawson and Snyder, 1994)</ref>. The inducible NOS (iNOS) is predominantly present in activated macrophages, but it can also be induced through transcription in various other cells. Its increased synthesis can be stimulated by cytokines, inflammation and other pathological processes <ref type="bibr" target="#b35">(Fo ¨rstermann et al., 1994;</ref><ref type="bibr">Nathan and Xie, 1994)</ref>.</p><p>NO is considered to be both an intercellular and intracellular messenger, having many diverse functions <ref type="bibr">(Dawson and Snyder, 1994)</ref>. Excessive production of NO is © Oxford University Press 1998 and inducible nitric oxide synthase which, by immunoelectron microscopy, were colocalized to clusters of tubulofilaments (previously shown, by us, to be paired helical filaments). Strong nitrotyrosine immunoreactivity was in the form of multiple dots and large granular patches, which ultrastructurally did not immunolocalize to tubulofilaments. Excess intracellular nitric oxide can combine with superoxide to produce highly toxic peroxynitrite, which can nitrate tyrosines of proteins. The presence of nitrotyrosine is indicative of nitric oxide-induced oxidative stress. Our data suggest that oxidative stress plays a role in the pathogenic cascade of hereditary inclusion-body myopathies. postulated to play an important pathogenic role in various diseases, including neurodegenerative, inflammatory and immunological processes <ref type="bibr" target="#b35">(Fo ¨rstermann et al., 1994;</ref><ref type="bibr">Nathan and Xie, 1994)</ref>. One of the mechanisms by which NO may contribute to the pathogenesis of various diseases involves reaction with superoxide to form the highly reactive, extremely toxic, oxidizing agent peroxynitrite, which in turn nitrates tyrosine components of proteins, resulting in various pathological processes. The presence of nitrotyrosine in a tissue is considered a marker of NO-induced oxidative stress <ref type="bibr" target="#b27">(Crow and Beckman, 1995;</ref><ref type="bibr">Beckman and Koppenol, 1996)</ref>. NO-induced oxidative stress has been recently demonstrated in Alzheimer's disease (brain) <ref type="bibr" target="#b36">(Good et al., 1996;</ref><ref type="bibr" target="#b58">Smith et al., 1997)</ref> and amyotrophic lateral sclerosis (spinal cord) <ref type="bibr" target="#b0">(Abe et al., 1995;</ref><ref type="bibr" target="#b26">Chou et al., 1996)</ref>, but its possible role in the pathogenesis of human muscle diseases is largely unknown.</p><p>Endothelial NOS has been shown to be immunolocalized in normal mitochondria isolated from several tissues including skeletal muscle <ref type="bibr" target="#b21">(Bates et al., 1996)</ref> and to be increased in ragged-red muscle fibres from patients with mitochondrial encephalomyopathies <ref type="bibr" target="#b50">(Ohkoshi et al., 1997)</ref>.</p><p>Recently, nitrotyrosine, nNOS and iNOS have been shown to be abnormally accumulated in vacuolated muscle fibres of sporadic inclusion-body myositis (s-IBM) <ref type="bibr" target="#b62">(Yang et al., 1996)</ref>. All three proteins immunocolocalized with phosphorylated tau and were mainly present on s-IBM paired helical filaments (which appear as less-well-defined 'tubulofilaments' in peroxidase-stained immunoelectron micrographs; see <ref type="bibr" target="#b4">Askanas and</ref><ref type="bibr">Engel, 1993, 1995)</ref>. To our knowledge, s-IBM is the first human muscle disease in which NO-induced oxidative stress has been demonstrated.</p><p>Because muscle biopsies of hereditary inclusion-body myopathies (h-IBM) have several pathological similarities to muscle biopsies of s-IBM, and some differences (reviewed in <ref type="bibr">Askanas and Engel, 1995)</ref>, we asked whether NO-induced oxidative stress is also associated with autosomal-recessive and autosomal-dominant inclusion-body myopathies (IBM).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p>We studied diagnostic muscle biopsies (obtained with informed consent approved by the University of Southern California School of Medicine Protection of Human Subjects Committee) from six Persian-Jewish patients with quadricepssparing autosomal-recessive IBM from five families (reviewed in <ref type="bibr">Askanas and Engel, 1995)</ref> and from three siblings with autosomal-dominant IBM <ref type="bibr" target="#b1">(Alvarez et al., 1996)</ref>. Control biopsies were: polymyositis (seven), dermatomyositis (three), morphologically non-specific-myopathy (seven), Duchenne muscular dystrophy (two), amyotrophic lateral sclerosis (three), myaesthenia gravis (one) and normal (five). Diagnosis of all patients was based on clinical and laboratory studies, including 18-reaction histochemistry of the muscle biopsy <ref type="bibr">(Engel, 1967)</ref>. All h-IBM patients had the typical h-IBM muscle phenotype, including cytoplasmic and nuclear paired helical filaments by electron microscopy and by immunoreactivity with SMI-31 antibody <ref type="bibr">(Askanas and Engel, 1995;</ref><ref type="bibr" target="#b1">Alvarez et al., 1996;</ref><ref type="bibr" target="#b17">Askanas et al., 1996a)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Light microscopic immunocytochemistry</head><p>Peroxidase-antiperoxidase and immunofluorescence staining techniques were used, as described previously <ref type="bibr" target="#b13">(Askanas et al., 1992</ref><ref type="bibr" target="#b14">(Askanas et al., , 1993a</ref><ref type="bibr">(Askanas et al., , b, 1994</ref><ref type="bibr" target="#b17">(Askanas et al., , 1996a;;</ref><ref type="bibr">Mirabella et al., 1996a, b)</ref>, on 10-µm unfixed transverse sections of fresh-frozen muscle biopsies using the antibodies listed in Table <ref type="table">1</ref>.</p><p>Antibodies against n-and iNOS were previously shown to be isoform-specific by the suppliers and others <ref type="bibr" target="#b39">(Hunot et al., 1996)</ref>. In our previous studies, the two antibodies had different patterns of immunoreactivity in normal muscle <ref type="bibr" target="#b62">(Yang et al., 1996)</ref>. iNOS, but not nNOS, was immunoreactive in muscle macrophages <ref type="bibr" target="#b62">(Yang et al., 1996)</ref>.</p><p>The following controls for staining specificity were used: (i) omission of the primary antibody or its replacement with normal rabbit serum; (ii) preabsorption of primary polyclonal antiserum against nitrotyrosine with purified nitrotyrosine (gift from Dr J. S. Beckman). To block non-specific binding of antibody to F c receptors, sections were preincubated with 1 : 10 diluted normal goat serum <ref type="bibr" target="#b13">(Askanas et al., 1992</ref><ref type="bibr" target="#b14">(Askanas et al., , 1993a</ref><ref type="bibr">(Askanas et al., , b, 1994</ref><ref type="bibr" target="#b17">(Askanas et al., , 1996a;;</ref><ref type="bibr" target="#b62">Yang et al., 1996)</ref>.</p><p>Double immunofluorescence was performed using polyclonal antiserum against either nNOS, iNOS or nitrotyrosine, combined with a monoclonal antibody SMI-31, which recognizes phosphorylated tau <ref type="bibr" target="#b17">(Mirabella et al., 1996a)</ref>, and is used for identification of IBM paired helical filaments <ref type="bibr" target="#b17">(Askanas et al., 1996a)</ref>. This technique utilized Texas-red and fluorescein isothiocyanate (FITC)-labelled secondary antisera as previously described by us. SMI-31, a mouse antibody directed against 200 kDa phosphorylated mammalian neurofilament <ref type="bibr" target="#b59">(Sternberger and Sternberger, 1983;</ref><ref type="bibr" target="#b60">Sternberger et al., 1985)</ref>, crossreacts on immunoblots with Alzheimer's disease and IBM paired helical filament-phosphorylated tau <ref type="bibr" target="#b40">(Ksiezak-Reding et al., 1987;</ref><ref type="bibr" target="#b49">Nukina et al., 1987;</ref><ref type="bibr" target="#b17">Mirabella et al., 1996a)</ref>. In IBM muscle, SMI-31 exclusively stains paired helical filaments <ref type="bibr" target="#b17">(Askanas et al., 1996a;</ref><ref type="bibr" target="#b17">Mirabella et al., 1996a)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunoelectron microscopy</head><p>This was performed on 10-µm thick unfixed frozen-sections adhered to the bottom of 34-mm Petri dishes, as described by <ref type="bibr" target="#b12">Askanas et al. (1991</ref><ref type="bibr" target="#b13">Askanas et al. ( , 1992</ref><ref type="bibr" target="#b14">Askanas et al. ( , 1993a</ref><ref type="bibr">Askanas et al. ( , b, 1994</ref><ref type="bibr" target="#b17">Askanas et al. ( , 1996a))</ref>. In brief, after incubation in a given primary antibody, sections were incubated in either gold-conjugated or HRP (horseradish peroxidase)-conjugated secondary antisera and processed for electron microscopy. The embedded section in the dish was viewed under phase-contrast microscopy. Vacuolated muscle fibres were identified and marked, and 1 mm diameter cores were drilled out. From the cores, each containing at least one vacuolated muscle fibre, thin sections were cut and examined by electron microscopy, either without counterstaining for horseradish-peroxidase reactions or following counterstaining with uranyl acetate and lead citrate for the gold label.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Light microscopy: immunocytochemistry</head><p>In all recessive and dominant IBM patients, ~75% of the vacuolated muscle fibres and 5-10% of non-vacuolated fibres were immunoreactive with antibodies against nNOS, iNOS and nitrotyrosine (Figs <ref type="figure" target="#fig_1">1 and 2</ref>). Immunoreactivity utilizing antibodies against nNOS and iNOS had the form of welldefined darkly positive inclusions, either within the vacuoles or in the vacuole-free cytoplasm (Figs <ref type="figure" target="#fig_1">1 and 2</ref>). By contrast,</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 Dilutions of primary antibodies used in immunocytochemistry</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Primary antibody Dilution</head><p>Mouse monoclonal against human nNOS (lot 4, Transduction Laboratories) 1 : 10 Rabbit polyclonal against human nNOS (lot 4, Transduction Laboratories) 1 : 100 Mouse monoclonal against human iNOS (lot 12, Transduction Laboratories) 1 : 10 Rabbit polyclonal against human nNOS (lot 7, Transduction Laboratories) 1 : 100 Mouse monoclonal against nitrotyrosine (gift from Dr J. S. <ref type="bibr">Beckman)</ref> 1 : 10 Rabbit polyclonal against nitrotyrosine (gift from Dr J. S. Beckman and lot 14693, Upstate Biotechnologies) 1 : 20 SMI-31 mouse monoclonal against phosphorylated neurofilament heavy-chain (Sternberg Monoclonal) 1 : 500 nitrotyrosine immunoreactivity was in the form of small multiple dots or large granular patches (Figs <ref type="figure" target="#fig_1">1 and 2</ref>). nNOS and iNOS immunoreactivities colocalized with SMI-31 immunoreactivity in 80-90% of the SMI-31 positive muscle fibres (Fig. <ref type="figure" target="#fig_2">3</ref>); however, nitrotyrosine immunoreactivity did not colocalize with SMI-31 immunoreactivity (not shown). The pattern of immunoreactivity with all the antibodies used did not differ between the recessive and the dominant forms of h-IBM.</p><p>When the primary antibody was omitted, or was replaced by non-immune serum, the immune reactions did not take place. Preabsorption of the antinitrotyrosine antiserum with purified nitrotyrosine markedly diminished or abolished the staining. None of the control muscle biopsies had NOS or nitrotyrosine immunoreactivity that was characteristic of h-IBM. As in our previous studies <ref type="bibr" target="#b62">(Yang et al., 1996</ref><ref type="bibr" target="#b63">(Yang et al., , 1997))</ref>, n-and iNOS, but not nitrotyrosine, were immunolocalized at the postsynaptic domain of the neuromuscular junction in  <ref type="figure">and D</ref>). SMI-31 antibody identifies phosphorylated tau of IBM paired helical filaments <ref type="bibr" target="#b17">(Askanas et al., 1996a)</ref>. All magnifications ϫ600.</p><p>normal and abnormal human muscle fibres, and in regenerating muscle fibres of various diseases.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunoelectron microscopy</head><p>nNOS and iNOS immunoreactivities were localized mainly to structures having a tubulofilamentous appearance (Fig. <ref type="figure" target="#fig_3">4</ref>). The normal parts of the muscle fibres adjacent to the tubulofilaments were not immunoreactive. Nitrotyrosine immunoreactivity was on amorphous-floccular material, 6-10 nm diameter filaments, and very thin (Ͻ 8 nm diameter) threads. Sometimes these were close to tubulofilaments, but the tubulofilaments themselves never contained nitrotyrosine immunoreactivity (Fig. <ref type="figure" target="#fig_3">4</ref>). The normal parts of the muscle fibres, including mitochondria and lipofuscin, did not contain nitrotyrosine immunoreactivity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>The hereditary h-IBM encompass several syndromes with autosomal-recessive or autosomal-dominant inheritance and progressive muscle weakness (reviewed in <ref type="bibr" target="#b4">Askanas and</ref><ref type="bibr">Engel, 1995, 1998a;</ref><ref type="bibr" target="#b57">Sivakumar and Dalakas, 1996;</ref><ref type="bibr">Askanas, 1997)</ref>. Clinical onset is usually in the second or third decade.</p><p>In the quadriceps-sparing form of autosomal-recessive h-IBM, linkage to chromosome 9p1-q1 has been established in various ethnic groups <ref type="bibr">(Argov et al., 1997;</ref><ref type="bibr" target="#b40">Ikeuchi et al., 1997;</ref><ref type="bibr">Middleton et al., 1997)</ref>, but the abnormal gene has not yet been identified <ref type="bibr">(Askanas, 1997)</ref>. In autosomal-dominant h-IBM, the chromosome(s) has not yet been identified. Muscle pathology of the h-IBM resembles s-IBM, but lacks lymphocytic inflammation, hence the terms 'myopathy' versus 'myositis' <ref type="bibr" target="#b53">(Askanas and Engel, 1993)</ref>. Pathological similarities between the h-IBM and s-IBM include: (i) vacuolar degeneration of muscle fibres; (ii) filamentous inclusions composed of paired helical filaments containing phosphorylated tau, which appear as tubulofilaments in electron micrographs of immunoperoxidase stained sections <ref type="bibr" target="#b16">(Askanas et al., 1994;</ref><ref type="bibr" target="#b17">Mirabella et al., 1996a)</ref>; and (iii) accumulations of βamyloid precursor protein (βAPP) epitopes <ref type="bibr" target="#b14">(Askanas et al., 1993a)</ref>, other Alzheimer-characteristic proteins, and prion <ref type="bibr" target="#b15">(Askanas et al., 1993b;</ref><ref type="bibr">reviewed in Askanas and Engel, 1995)</ref>. In contrast to s-IBM, in the h-IBM: (i) the majority of the vacuolated muscle fibres do not contain Congo-Red positivity (which denotes 'amyloid') <ref type="bibr">(Askanas and Engel, 1995;</ref><ref type="bibr" target="#b17">Mirabella et al., 1996a)</ref>; and (ii) h-IBM paired helical filaments lack some epitopes of phosphorylated tau <ref type="bibr" target="#b17">(Mirabella et al., 1996a)</ref> and do not contain apolipoprotein E <ref type="bibr" target="#b46">(Mirabella et al., 1996b)</ref>. Tables <ref type="table" target="#tab_1">2 and 3</ref> illustrate pathological similarities and differences between s-IBM and h-IBM.</p><p>The present study demonstrates increased accumulation of nNOS, iNOS and nitrotyrosine in abnormal muscle fibres of autosomal-recessive and autosomal-dominant IBM. The pattern of light microscopy immunoreactivity of nNOS and iNOS was like that of s-IBM, and both enzymes were localized to clusters of tubulofilaments by immunoelectron microscopy, as in s-IBM <ref type="bibr" target="#b62">(Yang et al., 1996)</ref>. In striking contrast to s-IBM, in the h-IBM abnormal muscle fibre, localized nitrotyrosine was not in the form of well-delineated strongly immunoreactive inclusions like those of nNOS and iNOS localization, but rather in the form of multiple small dots. In addition, electron microscopy showed that nitrotyrosine was not immunolocalized to tubulofilaments in the h-IBMs.</p><p>A possible explanation for the slightly distant localization of nitrotyrosine from the NOS might be that the freely diffusible NO moves into the cytoplasm from its site of origin, i.e. the NOS on tubulofilaments/paired helical filaments, and then combines with superoxide to form peroxynitrite, which subsequently nitrates proteins of other subcellular structures. Perhaps the molecular composition or configuration of the paired helical filaments in the h-IBM prevents their being nitrated to form nitrotyrosines (in contrast with s-IBM paired helical filaments which do contain nitrotyrosine).</p><p>The difference between the h-IBM and s-IBM regarding the presence of nitrotyrosine on tubulofilaments/paired helical filaments is of special interest. It is not known whether other molecular differences between paired helical filaments of sand h-IBM (Table <ref type="table" target="#tab_1">3</ref>) influence the nitration of proteins. For example, it is not known whether in s-IBM the presence of nitrotyrosine on paired helical filaments is secondary to the immunohistochemically demonstrated greater amount of phosphorylated epitopes of paired helical filament-tau compared with h-IBM <ref type="bibr" target="#b17">(Mirabella et al., 1996a)</ref>, and/or the presence of ApoE, which is not detectable in paired helical filaments in h-IBM <ref type="bibr" target="#b46">(Mirabella et al., 1996b)</ref>. Alternatively, (i) the hyperphosphorylation of paired helical filament-tau may be a consequence of the nitrotyrosine on paired helical filaments or (ii) nitrated tyrosine and tau-hyperphosphorylation are independent phenomena of the paired helical filaments. Recently, it has been shown that phosphorylation of  tau protein is, at least partially, mediated through tyrosine phosphorylation/dephosphorylation mechanisms <ref type="bibr" target="#b41">(Lu et al., 1994)</ref>, and peroxynitrite-mediated nitration of a single residue in the cell-cycle kinase cdc2 can influence tyrosine phosphorylation <ref type="bibr" target="#b37">(Gow et al., 1996)</ref>. Moreover, it has been shown in vitro that oxidative stress can induce formation of paired helical filaments <ref type="bibr" target="#b56">(Schweers et al., 1995)</ref>. Whether any of these mechanisms play a role in the IBM remains to be studied. Previously we showed that superoxide dismutase-1 (SOD1) and SOD1-mRNA are increased in vacuolated muscle fibres of autosomal-recessive h-IBM and s-IBM <ref type="bibr" target="#b18">(Askanas et al., 1996b)</ref>, suggesting an attempted protective response of those abnormal muscle fibres to increased superoxides. Superoxides can rapidly combine with increased NO to form the very toxic peroxynitrite, leading to subsequent nitration of tyrosine groups on proteins <ref type="bibr" target="#b27">(Crow and Beckman, 1995;</ref><ref type="bibr">Beckman and Koppenol, 1996)</ref>. The reasons for increased superoxides in h-IBM and s-IBM are not known. One possibility is that the mitochondrial abnormalities (both known and as yet unknown), including respiratory chain dysfunction, in s-IBM <ref type="bibr" target="#b51">(Oldfors et al., 1995;</ref><ref type="bibr" target="#b52">Santorelli et al., 1996;</ref><ref type="bibr" target="#b31">Desnuelle et al., 1998)</ref> are responsible for the generation of reactive oxygen species. However, because h-IBM muscle biopsies do not have (i) ragged-red fibres, (ii) cytochrome c oxidase negative muscle fibres or (iii) mitochondrial DNA deletions <ref type="bibr" target="#b31">(Desnuelle et al., 1998)</ref>, a mechanism based on mitochondrial abnormalities is not likely to be responsible for the oxidative stress occurring in h-IBM muscle.</p><p>We consider that in h-IBM, the lack of several abnormalities present in s-IBM reflects a slightly different, less complete, pathological change. For example, one can speculate that factors associated with the ageing cellular milieu, and possibly with inflammation, both occurring in s-IBM but not in the h-IBM, mediate nitration of proteins on paired helical filaments. s-IBM becomes clinically manifest after the age of 50 years and often between 60 and 80 years, whereas the h-IBM become manifest in the second or third decade of life. In the younger h-IBM muscle fibre, the less aged intracellular environment, lack of lymphocytic inflammation, or the specific h-IBM genetic microclimate may be the aspects leading to less advanced changes of paired helical filaments, including their lack of nitration and lack of congophilia.</p><p>The mechanisms and causes leading to the increased accumulation of nNOS and iNOS in the h-IBM are not known, but it is thought that iNOS is accumulated through increased transcription. The mechanism of abnormally accumulated nNOS is not known. Our in situ hybridization studies (in progress) using cDNA probes specific for iNOS and nNOS should help answer these questions.</p><p>Of possible relevance to both s-IBM and h-IBM is that β-amyloid protein (Aβ) can induce oxidative stress in a variety of cells <ref type="bibr" target="#b24">(Behl et al., 1994;</ref><ref type="bibr">reviewed in Butterfield, 1997)</ref> and can increase NOS in non-muscle cells <ref type="bibr" target="#b38">(Hu and Fakahany, 1993)</ref>. In Alzheimer's disease brain, increased iNOS was demonstrated in astrocytes adjacent to the Aβcontaining plaques <ref type="bibr" target="#b61">(Wallace et al., 1997)</ref>. We have shown that Aβ is abnormally accumulated in the vacuolated muscle fibres of s-IBM and h-IBM <ref type="bibr" target="#b13">(Askanas et al., 1992</ref><ref type="bibr" target="#b14">(Askanas et al., , 1993a))</ref>. Accordingly, the increased Aβ might be at least partly responsible for the increased NOS in both s-IBM and h-IBM vacuolated fibres.</p><p>Because abnormal accumulations of β-amyloid precursor protein (βAPP), including its Aβ portion, and βAPP-mRNA, occur in both s-IBM and h-IBM very early in the disease process, and precede other abnormalities <ref type="bibr" target="#b13">(Askanas et al., 1992;</ref><ref type="bibr" target="#b53">Sarkozi et al., 1993)</ref>, our current hypothesis is that over-expressed βAPP leads to oxidative stress in the IBM, which subsequently results in other abnormalities <ref type="bibr" target="#b11">(Askanas and Engel, 1998b)</ref>.</p><p>In accord with this hypothesis is our recent demonstration that βAPP overexpression, mediated by βAPP gene transfer into cultured normal human muscle fibres induces several aspects of the IBM phenotype, including vacuolization, cytochrome oxidase deficiency, mitochondrial structural abnormalities <ref type="bibr" target="#b19">(Askanas et al., 1996c</ref><ref type="bibr" target="#b20">(Askanas et al., , 1997))</ref>, and increased SOD1 and SOD1-mRNA <ref type="bibr" target="#b18">(Askanas et al., 1996b)</ref>.</p><p>In neither the h-IBM nor s-IBM is the pathogenic cascade well understood. The several forms of h-IBM, having different genetic transmission, probably have different genetic defects, and the aetiology of s-IBM is definitely different but still unknown-possibly viral <ref type="bibr">(Askanas and Engel, 1995;</ref><ref type="bibr" target="#b28">Cupler et al., 1996;</ref><ref type="bibr" target="#b34">Engel et al., 1997)</ref>. Since s-IBM and the recessive and dominant forms of h-IBM have several characteristic pathological features in common, we have suggested that in all the IBM there is a common pathological cascade into which various genetic (h-IBM) and acquired (s-IBM) dysfunctions <ref type="bibr">(Askanas, 1997;</ref><ref type="bibr" target="#b11">Askanas and Engel, 1998b)</ref> funnel.</p><p>The present study indicates that oxidative stress might be associated with a pathological cascade of the h-IBM. It also raises the possibility that a potential therapeutic avenue for the h-IBM is reduction of free radicals within the affected muscle fibres, and this might be achievable before the respective genetic defects are identified and become clinically correctable.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc>Fig.1Light microscopy. Peroxidase-antiperoxidase immunocytochemistry illustrating accumulation of nNOS (A and B), iNOS (C and D) and nitrotyrosine (NT: E and F) in abnormal muscle fibres of autosomal recessive h-IBM. Accumulation of nNOS and iNOS appears as well-defined, strongly immunoreactive inclusions. In C, the inclusion in the centre fibre is along the left surface of the fibre. NT immunoreactivity is in the form of multiple small dots (E) or a large granular patch (F). All magnifications ϫ600.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2</head><label>2</label><figDesc>Fig. 2 Light microscopy. Peroxidase-antiperoxidase immunocytochemistry illustrating accumulation of nNOS, iNOS and nitrotyrosine (NT) in abnormal muscle fibres of autosomaldominant h-IBM. nNOS and iNOS are accumulated in the form of large, dark inclusions. Nitrotyrosine is in the form of either dispersed multiple small dots (C) or clustered dots (D). Magnifications for A, B and D ϫ1200, and for C ϫ600.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3</head><label>3</label><figDesc>Fig. 3 Double-label immunofluorescence illustrating close colocalization of nNOS (A) and iNOS (C) with SMI-31 antibody (Band D). SMI-31 antibody identifies phosphorylated tau of IBM paired helical filaments<ref type="bibr" target="#b17">(Askanas et al., 1996a)</ref>. All magnifications ϫ600.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 4</head><label>4</label><figDesc>Fig.4Immunoelectron microscopy. Low (A and C) and higher (B and D) magnification of horseradish-peroxidase staining illustrating localization of nNOS and iNOS to paired helical filaments. Adjacent parts of normal myofibrils in A and C (lower part of each plate indicated by asterisks) are not stained. E and F show gold immunoelectron microscopy using 10 nm gold particles for nitrotyrosine (NT) immunolocalization. NT is immunolocalized to 8-10 nm filaments and very thin threads (Ͻ8 nm) (E) and to amorphous material in close proximity to paired helical filaments (F). Paired helical filaments themselves (two clusters of paired helical filaments in F are indicated by arrows) do not contain NT immunoreactivity. Adjacent portion of a normal myofibril (E, lower-left, indicated by asterisk) does not contain NT immunoreactivity. Magnifications for A and C ϫ26 000, for B and D ϫ53 000, for E ϫ67 200 and for F ϫ51 000. Bars represent 0.5 µm in A and C and 0.25 µm in B-F.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 2</head><label>2</label><figDesc>Pathological phenotypes of s-IBM and the h-IBMs</figDesc><table><row><cell>Pathology</cell><cell>s-IBM</cell><cell>h-IBMs</cell><cell>Reference</cell></row><row><cell>Similarities</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Vacuolated muscle fibres</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Askanas and Engel (1995) review</cell></row><row><cell>Ubiquitin* β-amyloid precursor protein* β-amyloid precursor protein-mRNA</cell><cell>ϩ ϩ ϩ</cell><cell>ϩ ϩ ϩ</cell><cell>Askanas et al. (1991) Askanas et al. (1993a) Sarkozi et al. (1993)</cell></row><row><cell>Prion protein*</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Askanas et al. (1993b)</cell></row><row><cell>Prion protein-mRNA</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Sarkozi et al. (1994)</cell></row><row><cell>Tau* with antibodies...</cell><cell></cell><cell></cell><cell></cell></row><row><cell>-SMI-31</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>-AT8</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>nNOS*</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Yang et al. (1996) and this paper</cell></row><row><cell>iNOS*</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Yang et al. (1996) and this paper</cell></row><row><cell>Differences</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Inflammation</cell><cell>ϩ</cell><cell>-</cell><cell>Askanas and Engel (1995) review</cell></row><row><cell>Ragged-red fibres</cell><cell>ϩ</cell><cell>-</cell><cell>Askanas and Engel (1995) review</cell></row><row><cell>COX-negative muscle fibres</cell><cell>ϩ</cell><cell>-</cell><cell>Askanas and Engel (1995) review</cell></row><row><cell>Congo-red positivity</cell><cell>ϩ</cell><cell>-</cell><cell>Askanas and Engel (1995) review</cell></row><row><cell>Tau* with antibodies</cell><cell></cell><cell></cell><cell></cell></row><row><cell>-SMI-310</cell><cell>ϩ</cell><cell>-</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>-PHF-1</cell><cell>ϩ</cell><cell>ϩ</cell><cell></cell></row><row><cell></cell><cell cols="2">(defined inclusions) (diffuse)</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>Apolipoprotein E*</cell><cell>ϩ</cell><cell>ϩ</cell><cell></cell></row><row><cell></cell><cell cols="2">(defined inclusions) (diffuse)</cell><cell>Mirabella et al. (1996b)</cell></row><row><cell>Nitrotyrosine*</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Yang et al. (1996) and this paper</cell></row><row><cell></cell><cell cols="2">(defined inclusions) (multiple dots)</cell><cell></cell></row></table><note>*Immunoreactivity. COX ϭ cytochrome oxidase; PHF ϭ paired helical filaments.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 3</head><label>3</label><figDesc>Ultrastructural immunoreactivities of various proteins on paired helical filaments (PHFs) of s-IBM and the h-IBMs</figDesc><table><row><cell>Protein</cell><cell>s-IBM</cell><cell>h-IBM</cell><cell>Reference</cell></row><row><cell>PHFs</cell><cell>PHFs</cell><cell>PHFs</cell><cell></cell></row><row><cell>Similarities β-amyloid precursor protein*</cell><cell>-</cell><cell>-</cell><cell>Askanas et al. (1993a)</cell></row><row><cell>Ubiquitin*</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Askanas et al. (1991)</cell></row><row><cell>Prion protein*</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Askanas et al. (1993b)</cell></row><row><cell>Phosphorylated tau* with antibodies</cell><cell></cell><cell></cell><cell></cell></row><row><cell>-SMI-31</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>-AT8</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>nNOS*</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Yang et al. (1996) and this paper</cell></row><row><cell>iNOS*</cell><cell>ϩ</cell><cell>ϩ</cell><cell>Yang et al. (1996) and this paper</cell></row><row><cell>Differences</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Tau* with antibodies</cell><cell></cell><cell></cell><cell></cell></row><row><cell>-SMI-310</cell><cell>ϩ</cell><cell>-</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>-PHF 1</cell><cell>ϩ</cell><cell>-</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>Apolipoprotein E*</cell><cell>ϩ</cell><cell>-</cell><cell>Mirabella et al. (1996b)</cell></row><row><cell>Nitrotyrosine*</cell><cell>ϩ</cell><cell>-</cell><cell>Yang et al. (1996) and this paper</cell></row><row><cell>Non-EM difference</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Congophilia</cell><cell>ϩ</cell><cell>-</cell><cell>Mirabella et al. (1996a)</cell></row><row><cell>*Immunoreactivity.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p>We wish to thank Dr Joseph Beckman for helpful discussions and the generous gift of his antibodies. Supported in part by grants from the National Institutes of Health, Muscular Dystrophy Association, Sheldon Katz ALS Research Fund and Helen Lewis Research Fund. C.-C.Y. was supported by the National Taiwan University Hospital.</p></div>
			</div>


			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Aβ ϭ β-amyloid protein; βAPP ϭ β-amyloid precursor protein; h-IBM ϭ hereditary-IBM; IBM ϭ inclusion body myopathy; iNOS ϭ inducible NOS; nNOS ϭ neuronal NOS; NO ϭ nitric oxide; NOS ϭ nitric oxide synthase; s-IBM ϭ sporadic-IBM; SOD ϭ superoxide dismutase</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Abe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Itoyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">199</biblScope>
			<biblScope unit="page" from="152" to="154" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Partial expression of cellular phenotype of sporadic inclusionbody myositis in autosomal dominant inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">A487</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Various types of hereditary inclusion body myopathies map to chromosome 9p1-q1</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tiram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Eisenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Seidman</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>see comments</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="421" to="422" />
			<date type="published" when="1997">1997. 1997</date>
		</imprint>
	</monogr>
	<note>Ann Neurol</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">New developments in hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>editorial; comment</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="548" to="551" />
			<date type="published" when="1997">1997. 1997</date>
		</imprint>
	</monogr>
	<note>Ann Neurol</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main">New advances in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="732" to="741" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="486" to="496" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Newest approaches to diagnosis and pathogenesis of sporadic inclusion-body myositis and hereditary inclusionbody myopathies, including molecular-pathologic similarities to Alzheimer disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Inclusion-body myositis and myopathies</title>
				<editor>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">G</forename><surname>Serratrice</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</editor>
		<meeting><address><addrLine>Cambridge</addrLine></address></meeting>
		<imprint>
			<publisher>Cambridge University Press. In press</publisher>
			<date type="published" when="1998">1998a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and hereditary inclusion-body myopathies-diseases of oxidative stress and aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<date type="published" when="1998">1998b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="73" to="76" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Light and electron microscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">β-amyloid precursor epitopes in muscle fibers of inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="551" to="560" />
			<date type="published" when="1993">1993a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Prion protein is abnormally accumulated in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">´f</forename><surname>Tome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leclerc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="25" to="28" />
			<date type="published" when="1993">1993b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Twisted tubulofilaments of inclusion-body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="177" to="187" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Use of antineurofilament antibody to identify paired-helical filaments in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="389" to="391" />
			<date type="published" when="1996">1996a</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Superoxide dismutase-1 gene and protein in vacuolated muscle fibers of sporadic inclusion-body myositis, hereditary inclusionbody myopathy, and cultured human muscle after β-amyloid precursor protein gene transfer</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Siddique</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">A487</biblScope>
			<date type="published" when="1996">1996b</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baquj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1314" to="1319" />
			<date type="published" when="1996">1996c</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">βAPP gene transfer into cultured human muscle induces inclusion-body myositis aspects</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">´s</forename><surname>Baque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2155" to="2158" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation?</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Bates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Loesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Burnstock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Clark</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">218</biblScope>
			<biblScope unit="page" from="40" to="44" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title level="m" type="main">Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Koppenol</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="C1424" to="1437" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Hydrogen peroxide mediates amyloid β protein toxicity</title>
		<author>
			<persName><forename type="first">C</forename><surname>Behl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lesley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schubert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Butterfield DA. β-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer&apos;s disease</title>
				<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="817" to="827" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Chem Res Toxicol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="495" to="506" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Role of SOD-1 and nitric oxide/ cyclic GMP cascade on neurofilament aggregation in ALS/MND</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Taniguchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="16" to="26" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The role of peroxynitrite in nitric oxidemediated toxicity</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Crow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Beckman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">The role of nitric oxide in physiology and pathophysiology. Current topics in microbiology and immunology</title>
				<editor>
			<persName><forename type="first">H</forename><surname>Koprowski</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">H</forename><surname>Maeda</surname></persName>
		</editor>
		<meeting><address><addrLine>Berlin</addrLine></address></meeting>
		<imprint>
			<publisher>Springer-Verlag</publisher>
			<date type="published" when="1995">1995</date>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="page" from="57" to="73" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Inclusion body myositis in HIV-1 and HTLV-1 infected patients</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Cupler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Monzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Semino-Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1887" to="1893" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">Gases as biological messengers: nitric oxide and carbon monoxide in the brain</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Dawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Snyder</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="5147" to="5159" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">mtDNA analysis in muscle of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Desnuelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Paquis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Saunie `res</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Inclusion-body myositis and myopathies</title>
				<editor>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">G</forename><surname>Serratrice</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</editor>
		<meeting><address><addrLine>Cambridge</addrLine></address></meeting>
		<imprint>
			<publisher>Cambridge University Press</publisher>
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main">Muscle biopsies in neuromuscular diseases</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Pediatr Clin North Am</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="963" to="995" />
			<date type="published" when="1967">1967</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis (s-IBM) in an HTLV-I-positive Iranian Muslim</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Haginoya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sabetian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bajoghli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">A124</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions</title>
		<author>
			<persName><forename type="first">U</forename><surname>Fo ¨rstermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Closs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nakane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1121" to="1131" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Evidence of neuronal oxidative damage in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Good</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Olanow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Perl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="21" to="28" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Gow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Duran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Malcolm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ischiropoulos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">385</biblScope>
			<biblScope unit="page" from="63" to="66" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">β-amyloid 25-35 activates nitric oxide synthase in a neuronal clone</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>El-Fakahany</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="760" to="762" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Nitric oxide synthase and neuronal vulnerability in Parkinson&apos;s disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hunot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Boissiere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Faucheux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Brugg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mouatt-Prigent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Agid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroscience</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="355" to="363" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ikeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Asaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Higuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="3410" to="3414" />
			<date type="published" when="1987">1997. 1987</date>
		</imprint>
	</monogr>
	<note>Ann Neurol</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Abnormal phosphorylation of tau proteins associated with bovine brain microtubules: activation by excess ATP and tyrosine dephosphorylation</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kanumury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Wood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="759" to="768" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title level="m" type="main">Molecular genetics of autosomal recessive hereditary inclusion body myopathy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Middleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Christodoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kyriakides</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>abstract</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">414</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<title level="m" type="main">Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>see comments</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1179" to="1180" />
			<date type="published" when="1996">1996a. 1996</date>
		</imprint>
	</monogr>
	<note>J Neuropathol Exp Neurol</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="864" to="872" />
			<date type="published" when="1996">1996b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title level="m" type="main">Regulation of biosynthesis of nitric oxide</title>
		<author>
			<persName><forename type="first">C</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q-W</forename><surname>Xie</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="13725" to="13728" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein</title>
		<author>
			<persName><forename type="first">N</forename><surname>Nukina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Kosik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="3415" to="3419" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Histological determination of nitric oxide synthase βNOS) and NADPH-diaphorase in ragged-red fibers from patients with mitochondrial encephalomyopathies</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ohkoshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mizusawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shoji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="151" to="156" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Mitochondrial DNA deletions in muscle fibers in inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A-R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I-M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Holme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N-G</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="581" to="587" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Santorelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sciacco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tanji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shanske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Vu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Golzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="789" to="795" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Alvarez RB. βamyloid precursor protein mRNA is increased in inclusion-body myositis muscle</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="815" to="818" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<monogr>
		<title level="m" type="main">Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusionbody myositis and hereditary inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>see comments</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="1261" to="1264" />
			<date type="published" when="1994">1994. 1994</date>
		</imprint>
	</monogr>
	<note>Am J Pathol</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments</title>
		<author>
			<persName><forename type="first">O</forename><surname>Schweers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E-M</forename><surname>Mandelkow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biernat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mandelkow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="8463" to="8467" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">The spectrum of familial inclusion body myopathies in 13 families and a description of a quadricepssparing phenotype in non-Iranian Jews</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="977" to="984" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Widespread peroxynitrite-mediated damage in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Richey</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Sayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="2653" to="2657" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Sternberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Sternberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="6126" to="6130" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Aberrant neurofilament phosphorylation in Alzheimer disease</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Sternberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Sternberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ulrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="4274" to="4276" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Geddes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Farquhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Masson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="266" to="272" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Increase of nitric oxide synthases and nitrotyrosine in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Immunolocalization of nitric oxide synthases at the postsynaptic domain of human and rat neuromuscular junctions -light and electron microscopic studies</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Haun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="34" to="44" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
